XHLD vs SKIN vs HIMS vs ELF

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -11. 4% for TEN Holdings, Inc. Common Stock (XHLD). e. l. f. Beauty, Inc. (ELF) offers the better valuation at 32. 2x trailing P/E (19. 9x forward), making it the more compelling value choice. Analysts rate e. l. f. Beauty, Inc. (ELF) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, e.

l. f. Beauty, Inc. (ELF) is the cheapest at 32. 2x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, e. l. f. Beauty, Inc. is actually cheaper at 19. 9x.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: HIMS returned +161. 9% versus SKIN's -91. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Beauty Health Company (SKIN) is the lower-risk stock at 2.

00β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 20% more volatile than SKIN relative to the S&P 500. On balance sheet safety, e. l. f. Beauty, Inc. (ELF) carries a lower debt/equity ratio of 41% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -11. 4% for TEN Holdings, Inc. Common Stock (XHLD). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to -376. 7% for TEN Holdings, Inc. Common Stock. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

e.

l. f. Beauty, Inc. (ELF) is the more profitable company, earning 8. 5% net margin versus -628. 5% for TEN Holdings, Inc. Common Stock — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ELF leads at 12. 0% versus -432. 5% for XHLD. At the gross margin level — before operating expenses — XHLD leads at 78. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, e.

l. f. Beauty, Inc. (ELF) trades at 19. 9x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 31. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ELF: 54. 0% to $95. 17.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Hims & Hers Health, Inc.

(HIMS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+161. 9% 10Y return). The Beauty Health Company (SKIN) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HIMS: +161. 9%, SKIN: -91. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (XHLD (Communication Services) and SKIN (Consumer Defensive) and HIMS (Healthcare) and ELF (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: XHLD is a small-cap quality compounder stock; SKIN is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock; ELF is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.